This is the text extract for 2010-02 Schedule Dispatch, browse documents here.

18 January 2010 February 2010 Pharmaceutical Schedule Dispatch This document is provided to pharmacists as an early notification of the changes to be announced in the February 2010 Update to the Pharmaceutical Schedule. Please notify PHARMAC (0800 66 00 50) to change or remove your contact details.

New listings  Blood glucose diagnostic test meter (On Call Advanced) meter – subsidy by endorsement (p’code 2338378)  Blood glucose diagnostic test strip (On Call Advanced) blood glucose test strips x 50 and lancets x 5, 1 OP – subsidy by endorsement (p’code 2338386)  Sumatriptan (Arrow-Sumatriptan) tab 50 mg (p’code 2347008) and 100 mg (p’code 2347016), 100 tab packs  Risperidone (Apo-Risperidone) tab 0.5 mg (p’code 2329581), 1 mg (p’code 2329603), 2 mg (p’code 2329611), 3 mg (p’code 2329638) and 4 mg (p’code 2329646), and oral liq 1 mg per ml (p’code 2331047)  Risperidone (Dr Reddy’s Risperidone) tab 1 mg (p’code 2343088), 2 mg (p’code 2343096), 3 mg (p’code 2343118) and 4 mg (p’code 2343126)  Methylphenidate hydrochloride extended-release (Ritalin LA) cap modified-release 10 mg – Special Authority – Retail pharmacy – only on a controlled drug form (p’code 2346370)  Dasatinib (Sprycel) tab 100 mg – Special Authority (p’code 2347261)  Letrozole (Letara) tab 2.5 mg (p’code 2340402)  Promethazine hydrochloride (Promethazine Winthrop Elixir) oral liq 5 mg per 5 ml (p’code 2347407)  Fluticasone propionate (Flixonase Hayfever & Allergy) metered aqueous nasal spray, 50 μg per dose, 120 dose OP (p’code 409448) Changes to restrictions  Pregnancy tests – HCG urine (MDS Quick Card) cassette – Only on a PSO, up to 200 test available on a PSO – addition of OP  Influenza vaccine (Fluvax, Fluarix, Vaxigrip) inj – amended access criteria  Exemestane (Aromasin) tab 25 mg – additional subsidy by Special Authority – Retail pharmacy – repeat dispensings for Aromasin tab 25 mg will be fully subsidised where the initial dispensing was before 1 February 2010 Increased subsidy

Chemical Flecainide acetate Presentation Tab 50 mg and 100 mg Cap long-acting 100 mg and 200 mg Inj 10 mg per ml, 15 ml Tab 25 mg and 100 mg Fully brands subsidised

Tambocor Tambocor CR Tambocor Viagra

Sildenafil

A331666 Page 1 of 2

Decreased subsidy

Chemical Anastrozole Calcipotriol Presentation Tab 1 mg Crm 50 µg per g, 30 g OP and 100 g OP Oint 50 µg per g , 30 g OP and 100 g OP Soln 50 µg per ml, 30 ml OP and 60 ml OP Cap 0.25 µg and 0.5 µg Inj 1 mg for ECP Tab 25 mg Inj 3.6 mg and 10.8 mg Inj 1 mg per ml, 1 ml Fully brands subsidised Partially brands subsidised

Arimidex DP-Anastrozole* Daivonex

Calcitriol Docetaxel Exemestane Goserelin acetate Hydroxocobalamin

Calcitriol-AFT Airflow* Baxter Aromasin** Zoladex ABM Hydroxocobalamin Neo-B12* Betaloc-CR Metoprolol – AFT CR* Lyderm Sandomigran*** Arrow-Sumatriptan Sumagran Imigran

Metoprolol succinate Permethrin Pizotifen Sumatriptan

Tab long-acting 23.75 mg, 47.5 mg, 95 mg, and 190 mg Crm 5 % Tab 500 µg Tab 50 mg and 100 mg

*Indicates no change in price or subsidy is occurring to that brand from 1 February 2010 ** Fully subsidised with Special Authority *** Decreased price to match subsidy

NB. For the magnitude of the above price changes, please consult the online version of the Update to the Pharmaceutical Schedule at: www.pharmac.govt.nz/healthpros/Schedule

Consultation on proposal to amend claiming for Cost Brand Source prescriptions

PHARMAC is seeking feedback on a proposal to amend the way Cost Brand Source (CBS) prescriptions are annotated when claimed. Pharmacists would no longer be required to annotate the paper copy of the prescriptions with the cost, brand and source of supply of the medicine, but instead attach a copy of the purchase invoice to the prescription. The electronic claiming process would remain unchanged. PHARMAC welcomes feedback on this proposal. To provide feedback, please submit it in writing by 5 pm on Friday 22 January 2010. Full details of this consultation can be found on the PHARMAC website at http://www.pharmac.govt.nz/consultation and copies were provided to pharmacy organisations early last week for their comment on behalf of their members. We also welcome feedback from individual pharmacies.

Testosterone undecanoate capsules - delayed

Due to unforeseen air freight delays, the Arrow Pharmaceuticals brand of testosterone undecanoate cap 40 mg (Arrow-Testosterone) listing has been delayed from 1 February to 1 March 2010. Subsequent reference pricing and delisting of currently listed brands has also been delayed. A331666 Page 2 of 2